4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0000899243-16-017489
Options or other derivatives
- Chief Commercial Officer acquired 79,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Secor Alicia · Chief Commercial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2016-03-31 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | −53,000 | 53,000 | D |
| 2016-03-31 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | −26,500 | 26,500 | D |
Loading xslF345X03/doc4.xml…